In general, it's not surprising that variants like 501.V2 and B.1.1.7 have emerged; all viruses pick up mutations as they make copies of themselves, and the novel coronavirus called SARS-CoV-2 is no ...
The transmissibility of the novel coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is high, while most infections appear to be very mild or asymptomatic. This has led ...
One of the biggest and most pressing questions to arise about new SARS-CoV-2 variants like B.1.1.7, the so-called UK variant with 17 distinct mutations, and the so-called South African variant 501.V2 ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Moderna has become the first vaccine maker to produce a shot targeted at the virus variant discovered in South ...
Moderna has said it is developing a new vaccine against the coronavirus variant first detected in South Africa as an “insurance policy”, adding that its current jab still remains effective against the ...
Serum samples from 20 individuals who received the Pfizer-BioNTech vaccine against SARS-CoV-2 thwarted a version of the coronavirus with the so-called N501Y mutation, according to a preprint posted to ...
Top infectious disease expert Anthony Fauci has told Newsweek he would be "surprised" if a new, more infectious strain of COVID from South Africa had not arrived in the U.S., even though it has not ...
It’s a new year but coronavirus is showing no signs of slowing down, unfortunately. In fact, it’s mutating. The new B.1.1.7 strain that made headlines two weeks ago is theorized to have originated in ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Initial evidence that the Oxford/AstraZeneca vaccine offered only “minimal” protection against mild to moderate ...
NATURAL SELECTION is a powerful force. In circumstances that are still disputed, it took a bat coronavirus and adapted it to people instead. The result has spread around the globe. Now, in two ...
Scientists are testing if COVID-19 vaccines will protect against newly identified UK and South African SARS-CoV-2 variants, both of which contain an unusual number of mutations compared to other ...